The results of the validation group analysis showed a significant increase (P<0.001) in the expression of PSAT1 and PSRC1, and showed a significant decrease (P<0.001) in the expression of COLEC12, PLLP, and HP in SCLC group, as shown in Figure 11. This evidence concerns the gene PSAT1 and small cell lung carcinoma.